Newly Discovered Protein Facilitates TBE Virus Entry into Brain Cells
Scientists have discovered that the protein LRP8 on cell surfaces is essential for the tick-borne encephalitis (TBE) virus to infect human brain cells, opening new possibilities for targeted treatments.
Researchers from the Karolinska Institutet and international partners have identified a key protein on cell surfaces that is essential for the tick-borne encephalitis (TBE) virus to infect human cells. The study, published in Nature, reveals that the protein LRP8 acts as a critical receptor enabling the virus to cross cellular barriers and invade brain cells. This breakthrough was achieved by exposing a vast library of genetically modified cells to the virus, pinpointing LRP8 as the crucial factor; cells lacking this protein survived infection, indicating its vital role. LRP8 is highly expressed in brain tissue, making it especially relevant to the neurological impacts of TBE.
The virus is predominantly transmitted through tick bites, which can lead to severe neurological diseases. Its prevalence is increasing across Europe and Asia, paralleling the rise in tick populations. Despite the availability of a vaccine, there are no targeted treatments for individuals already infected. As a biosafety level 4 pathogen, TBE requires strict laboratory protocols.
The study demonstrated that the TBE virus’s surface protein specifically binds to LRP8, exploiting this receptor to gain entry into cells—particularly neurons in the brain. Understanding this mechanism opens new avenues for developing antiviral drugs that block this interaction, potentially preventing infection or reducing its severity. Notably, this research marks the first identification of a direct host cell receptor for a flavivirus, a family of viruses that includes yellow fever, dengue, and Japanese encephalitis, which are typically transmitted by mosquitoes or ticks.
Future research aims to understand how LRP8 facilitates the virus’s pathogenic effects within the brain’s neuronal network. The discovery offers hope for innovative therapies that can inhibit the initial stages of TBE virus infection, significantly impacting public health in endemic areas.
Source: https://medicalxpress.com/news/2025-09-key-protein-borne-encephalitis-revealed.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Understanding Dystonia: A Hidden but Impactful Movement Disorder
Dystonia is a complex and often underdiagnosed movement disorder characterized by involuntary muscle contractions, leading to abnormal movements and postures. Learn about its causes, symptoms, and treatment options.
New Insights into How the Brain Constructs Neural Networks for Motor Memories
Recent research reveals how the brain constructs and refines neural networks for motor memories, offering new insights into movement learning and potential therapies for Parkinson's disease.
New Research Identifies PTP1B as a Key Target to Protect the Heart in Obesity and High-Fat Diet Conditions
Research from MMRI identifies PTP1B enzyme as a key driver in obesity-related heart dysfunction, opening new avenues for targeted therapy to protect cardiac health.
Peer Influence Significantly Contributes to Youth Vaping Crisis, New Research Shows
Research from the University of Queensland highlights how peer influence drives the increasing trend of vaping and cannabis use among adolescents, emphasizing the need for targeted regulation and awareness campaigns.